|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
24,880,000 |
Market
Cap: |
11.39(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.465 - $2.37 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Eyenovia is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its microdose array print (MAP) platform technology, branded the Optejet®. MicroPine is Co.'s topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. MicroLine is Co.'s pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens that causes the gradual loss of the eye's ability to focus on near objects and impairs near visual acuity. Mydcombi is Co.'s fixed combination formulation of tropicamide-phenylephrine for mydriasis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
1,592,222 |
1,692,222 |
1,762,649 |
1,981,686 |
Total Buy Value |
$1,042,577 |
$1,140,577 |
$1,233,736 |
$1,726,261 |
Total People Bought |
2 |
2 |
3 |
6 |
Total Buy Transactions |
3 |
4 |
8 |
20 |
Total Shares Sold |
0 |
0 |
0 |
234,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$1,148,560 |
Total People Sold |
0 |
0 |
0 |
2 |
Total Sell Transactions |
0 |
0 |
0 |
5 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Grant Stuart M. |
|
|
2024-03-28 |
4 |
B |
$0.98 |
$98,000 |
D/D |
100,000 |
5,430,715 |
0.01 |
-11% |
|
Grant Stuart M. |
|
|
2024-03-19 |
4 |
B |
$1.23 |
$61,500 |
D/D |
50,000 |
5,330,715 |
0.01 |
21% |
|
Grant Stuart M. |
|
|
2024-03-08 |
4 |
B |
$1.58 |
$16,911 |
D/D |
10,717 |
5,280,715 |
0.01 |
-30% |
|
Rowe Michael M |
Chief Executive Officer |
|
2023-12-04 |
4 |
B |
$1.36 |
$6,650 |
D/D |
4,890 |
32,927 |
2.81 |
-60% |
|
Geltzeiler Michael S |
Director |
|
2023-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
19,814 |
19,814 |
|
- |
|
Strahlman Ellen R |
Director |
|
2023-09-29 |
4 |
B |
$1.68 |
$8,098 |
D/D |
4,820 |
75,113 |
2.39 |
7% |
|
Rowe Michael M |
Chief Executive Officer |
|
2023-09-19 |
4 |
B |
$1.66 |
$2,324 |
D/D |
1,400 |
28,037 |
2.73 |
18% |
|
Rowe Michael M |
Chief Executive Officer |
|
2023-09-15 |
4 |
B |
$1.75 |
$1,990 |
D/D |
1,137 |
26,637 |
2.73 |
-9% |
|
Grant Stuart M. |
|
|
2023-08-17 |
4 |
B |
$1.87 |
$56,100 |
D/D |
30,000 |
5,269,998 |
0.01 |
8% |
|
Grant Stuart M. |
|
|
2023-08-16 |
4 |
B |
$1.91 |
$85,815 |
D/D |
45,000 |
5,239,998 |
0.01 |
-9% |
|
Ianchulev Tsontcho |
Director |
|
2023-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,241 |
348,452 |
|
- |
|
Palanki Ram |
Director |
|
2023-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,241 |
37,428 |
|
- |
|
Jacobson Rachel |
Director |
|
2023-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,241 |
42,752 |
|
- |
|
Strahlman Ellen R |
Director |
|
2023-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,241 |
70,293 |
|
- |
|
Mather Charles E Iv |
Director |
|
2023-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
17,241 |
94,785 |
|
- |
|
Gandolfo John P |
Chief Financial Officer |
|
2023-05-31 |
4 |
B |
$2.79 |
$5,580 |
D/D |
2,000 |
8,000 |
2.74 |
-46% |
|
Kern Bren |
Chief Operating Officer |
|
2023-05-26 |
4 |
B |
$2.73 |
$6,825 |
D/D |
2,500 |
2,500 |
2.74 |
-39% |
|
Mather Charles E Iv |
Director |
|
2023-05-26 |
4 |
B |
$2.49 |
$7,470 |
D/D |
3,000 |
77,544 |
2.39 |
-39% |
|
Grant Stuart M. |
|
|
2023-05-25 |
4 |
B |
$2.65 |
$233,855 |
D/D |
88,247 |
5,194,998 |
0.01 |
-36% |
|
Strahlman Ellen R |
Director |
|
2023-05-23 |
4 |
B |
$3.10 |
$30,976 |
D/D |
10,000 |
53,052 |
2.39 |
-49% |
|
Mather Charles E Iv |
Director |
|
2023-05-15 |
4/A |
B |
$3.39 |
$13,560 |
D/D |
4,000 |
74,544 |
2.39 |
- |
|
Mather Charles E Iv |
Director |
|
2023-05-15 |
4 |
S |
$3.39 |
$13,560 |
D/D |
(4,000) |
74,544 |
|
51% |
|
Ianchulev Tsontcho |
Director |
|
2023-05-01 |
4 |
S |
$5.50 |
$495,000 |
D/D |
(90,000) |
331,211 |
|
67% |
|
Rowe Michael M |
Chief Executive Officer |
|
2023-05-01 |
4 |
OE |
$2.72 |
$27,200 |
D/D |
10,000 |
25,500 |
|
- |
|
Ianchulev Tsontcho |
Director |
|
2023-04-27 |
4 |
S |
$5.00 |
$300,000 |
D/D |
(60,000) |
421,211 |
|
63% |
|
143 Records found
|
|
Page 1 of 6 |
|
|